English | 简体中文 | 繁體中文 | 한국어 | 日本語
Monday, 7 March 2011, 15:00 HKT/SGT
Share:
    

Source: China Medical System Holdings Limited
China Medical System Accredited by 'China's Top 100 Potential Enterprises' by Forbes China for Two Consecutive Years

HONG KONG, Mar 7, 2011 - (ACN Newswire) - China Medical System Holdings Limited ("CMS" or the "Company", SEHK: 867), a leading China-based pharmaceutical services company focusing on the marketing, promotion and sale of prescription drugs, is pleased to announce that the Company was accredited as "China's Top 100 Potential Enterprises" among the list compiled by the Forbes China in February 2011. CMS has been selected on the list for two consecutive years.

Compiled by Forbes China, the "China's Top 100 Potential Enterprises" list focuses on the SMEs in China, and is the first ranking of its kind to cover the SMEs across all industries. This is the second consecutive year that CMS has won the coveted accolade for its outstanding business performance and contribution to the development of China's SMEs, and for its efforts to strive for excellence in its field.

About "China's Top 100 Potential Enterprises" by Forbes China
http://www.forbeschina.com/list/1008/more

Contact:
Hill and Knowlton Asia Ltd.

Crystal Yip  
Tel: +852 2894 6211 / 9720 6445
Email: crystal.yip@hillandknowlton.com.hk

James Wong
Tel: +852 2894 6216 / 9300 2263
Email: james.wong@hillandknowlton.com.hk



Topic: Awards
Source: China Medical System Holdings Limited

Sectors: BioTech
https://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2026 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

China Medical System Holdings Limited Related News
Apr 27, 2026 19:35 HKT/SGT
康哲藥業就已上市原研藥靜脈鐵劑莫諾菲和科莫非簽訂獨家商業化與供應協議
Apr 27, 2026 19:24 HKT/SGT
康哲药业就已上市原研药静脉铁剂莫诺菲和科莫非签订独家商业化与供应协议
Apr 27, 2026 19:00 HKT/SGT
CMS (867.HK/8A8.SG) Signed An Exclusive Commercialization and Supply Agreement for Marketed Originator Intravenous Iron Products Monofer(R) and Cosmofer(R)
Apr 23, 2026 22:00 HKT/SGT
CMS (867.HK; 8A8.SG): NDA for the Seasonal Allergic Rhinitis Indication of Class 1 Innovative Drug MG-K10 Accepted in China
Apr 23, 2026 19:48 HKT/SGT
康哲药业:1类新药MG-K10季节性过敏性鼻炎适应症NDA获受理
More news >>
Copyright © 2026 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575